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Objective:Whitematter hyperintensities (WMHs) are commonwith age, growover time, and are associatedwith
cognitive and motor impairments. Mechanisms underlying WMH growth are unclear. We aimed to determine
the presence and extent of decreased normal appearing white matter (NAWM) cerebral blood ﬂow (CBF)
surrounding WMHs to identify ‘WM at risk’, or the WMH CBF penumbra. We aimed to further validate cross-
sectional ﬁnding by determining whether the baseline WMH penumbra CBF predicts the development of new
WMHs at follow-up.
Methods: Sixty-one cognitively intact elderly subjects received 3 TMPRAGE, FLAIR, and pulsed arterial spin label-
ing (PASL). Twenty-four subjects returned for follow-up MRI. The inter-scan interval was 18 months. A NAWM
layer mask, comprised of ﬁfteen layers, 1 mm thick each surrounding WMHs, was generated for periventricular
(PVWMH) and deep (DWMH)WMHs.MeanCBF for each layerwas computed. NewWMHandpersistent NAWM
voxels for each penumbra layer were deﬁned from follow-up MRI.
Results: CBF in the area surrounding WMHs was signiﬁcantly lower than the total brain NAWM, extending ap-
proximately 12mmfromboth the establishedPVWMHandDWMH.Voxelswith newWMHat follow-up had sig-
niﬁcantly lower baseline CBF than voxels that maintained NAWM, suggesting that baseline CBF can predict the
development of new WMHs over time.
Conclusions: A CBF penumbra exists surrounding WMHs, which is associated with future WMH expansion. ASL
MRI can be used to monitor interventions to increase white matter blood ﬂow for the prevention of further
WM damage and its cognitive and motor consequences.© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
White matter hyperintensities (WMHs) are common with age and
grow over time (de Leeuw et al., 2001; Erten-Lyons et al., 2013;
Maillard et al., 2012; Silbert et al., 2012). WMHs are commonly classi-
ﬁed as periventricular (PVWMH) and deep (DWMH) lesions according
to their locations and appearance. The volume of WMHs is associated
with increased risk of cognitive (Au et al., 2006; Debette et al., 2010;VWMH, periventricular white
perintensity; NAWM, normal
, pulsed arterial spin labeling;
ntinuous arterial spin labeling;
g white matter layer 1; NAWM
Layton Aging and Alzheimer3s
ity, 3181 SW Sam Jackson Park
l), lahnad@ohsu.edu (D. Lahna),
e), ertenlyo@ohsu.edu
ertl@ohsu.edu (L.C. Silbert).
. This is an open access article underDeCarli et al., 1995a; Longstreth et al., 1996; Silbert et al., 2008; Silbert
et al., 2009) and motor (Silbert et al., 2008) impairment, stroke
(Debette et al., 2010; Kuller et al., 2004; Wen and Sachdev, 2004), and
mortality (Debette et al., 2010). Therefore, characterizing the growth
of WMH volume over time has become an important research goal in
order to impede the progression of clinical impairments.WMHs are likely
ischemic in origin (Fazekas et al., 1993), speciﬁcally arteriolosclerosis
(Erten-Lyons et al., 2013) and chronic hypoperfusion due to localization
on the border zones of cerebral arteries (Kim et al., 2008). Yet the exact
developmental process remains unclear.
The WMH penumbra is normal appearing white matter (NAWM)
tissue surrounding WMHs that is more vulnerable than other healthy
white matter (WM) to convert to WMHs (Maillard et al., 2011), or
‘WM at risk’. A previous diffusion tensor imaging (DTI) study has
shown that theWMHDTI-fractional anisotropy (FA) penumbrawas ap-
proximately 3 mm from voxels comprised of WMHs (Maillard et al.,
2011). Longitudinal studies also showed changes in baseline FA and
FLAIR signal intensities in a WMH penumbra deﬁned within 8 mm of
WMH lesions (Maillard et al., 2014), which could predict incidentthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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er study also demonstrated theWMHpenumbra as being a predilection
site for new lacunes (Duering et al., 2013). While previous penumbra-
deﬁningmethods capture currentmicrostructuralWM integrity disrup-
tion, arterial spin labeling can provide cerebral blood ﬂow (CBF) infor-
mation, which may serve to elucidate the etiology of WMH expansion
prior to microstructural injury to the WM.
Pulsed arterial spin labeling (PASL) is capable of measuring WMH
and NAWM cerebral blood ﬂow. It has been shown previously that
WMH CBF was signiﬁcantly lower than NAWM CBF (Brickman et al.,
2009). Therefore, lower CBF in the NAWM voxels surrounding WM le-
sions could be a suitablemarker for indicating theWMHCBF penumbra.
The aims of this studywere to determine the presence and extent of low
NAWM CBF surrounding WMHs to identify ‘WM at risk’, or the WMH
CBF penumbra. We aimed to further validate cross-sectional ﬁndings
by determining whether our previously identiﬁed baseline WMH CBF
penumbra predicted the development of new WMHs at follow-up
using longitudinal data. CBF delineation of the WMH penumbra could
provide a potentially modiﬁable biomarker to identify ‘at risk’ tissue,
for which interventions to prevent the accretion of WMH could be
implemented.
2. Material and methods
2.1. Subjects
Sixty-one cognitively intact community dwelling elderly subjects
currently participating in a Layton Aging and Alzheimer3s Disease Cen-
ter were recruited. Entry inclusion criteria included seniors aged 65 or
above with a score of 0 on the Clinical Dementia Rating Scale (CDR)
and ≥24 on the Mini-Mental State Examination. MRI exclusion criteria
included a history of clinical stroke or evidence of cortical stroke on
MRI, claustrophobia, inability to lie in a supine position for 90 min,
and implanted metallic objects. All subjects signed written informed
consent and approval from the Institutional Review Board of Oregon
Health & Science University was obtained. All subjects received at
least one brain MRI scan. Twenty-four subjects returned for a follow-
up MRI. The mean (standard deviation, SD) interscan interval was 18
(11) months. Table 1 describes participant characteristics.
2.2. MRI sequences
Magnetic resonance imaging (MRI) data were obtained using a 3.0 T
MRI scanner (TIM Trio System, Siemens Medical Solutions). Each sub-
ject underwent T1-weighted magnetization prepared rapid gradient
echo (MPRAGE), ﬂuid attenuated inversion recovery (FLAIR), and
QUIPSS II with thin-slice TI periodic saturation (Q2TIPS) PASL (Luh
et al., 1999). T1-weighted images were acquired using repetition timeTable 1
Summary of participant characteristics at baseline.
Variables Mean (SD) Median IQR
Number of subjects 61
Age (years) 84.6 (8.0) 85.2 9
Female 48
Percent number of subjects with history of
hypertension
73%
CDR 0 0 0
MMSE 28.9 (1.4) 29 2
Baseline total WMH volume (cc) 11.2 (9.5) 9.2 10.2
Baseline periventricular (PV) WMH volume (cc) 9.8 (9.1) 7.8 7.5
Baseline deep WMH volume (cc) 1.3 (1.4) 0.8 1.2
Baseline total brain NAWM volume (cc) 156.3 (36.3) 146.9 54.2
Baseline brain volume (cc) 837.0
(100.8)
818.2 115.6
Baseline intracranial volume (cc) 1860.3
(229.3)
1804.5 258.1
IQR = interquartile range; CDR = Clinical Dementia Rating Scale.(TR) = 2300 ms, echo time (TE) = 3.4 ms, inversion time (TI) =
1200 ms, spatial resolution = 1 mm isotropic, and ﬁeld of view
(FOV) = 256 mm. Axial 2D FLAIR datasets were acquired using TR =
9000ms, TE= 87ms, TI = 2500ms, FOV= 248mm, slice thickness=
2mm, andnumber of slices=95. PASL sequencewas obtained covering
the basal ganglia inferiorly, through the centrum semiovale superiorly
with following parameters: resolution = 3 × 3 × 4 mm, 2 mm gap,
time between the inversion pulse and beginning of the periodic satura-
tion pulse train 1 (TI1) = 700 ms, the post-TI periodic saturation stop
time (TI1s) = 1600 ms, the time between the inversion pulse and the
initial EPI read pulse (TI2) = 1800 ms (Campbell and Beaulieu, 2006),
TR = 3000 ms and TE = 13 ms. The sequence acquired 720 images in
3 separate runs. Subjects were instructed to stay awake with their
eyes closed.
2.3. MRI processing
For each dataset, the T1-weighted image was segmented into WM,
gray matter (GM), and ventricle masks using FreeSurfer (v.5.1), and
manually corrected for any tissue misclassiﬁcation. The masks were
then linearly aligned to the FLAIR image, and were later used to set
the boundaries of the seed growing for the WMHs. To determine the
WMH area, a histogram of the WM of FLAIR intensity was generated
and the 45% above peak of the histogram was used as a cutoff to sepa-
rate the WMH (Ncutoff) and NAWM (bcutoff). Clusters of at least
three voxelswere used as seeds for a custom cluster-growing algorithm.
For each cluster, the mean intensity was calculated and then all nearest
neighbor voxels of intensity exceeding 95% of themean cluster intensity
were added to the cluster. The process was repeated until the cluster
mean reached the lower limit of two standard deviations above the
WM mean or until no additional voxels met the threshold. The WMH
clusters were visually examined and manually corrected for accurate
WMH coverage. WMH clusters contiguous with the ventricles were la-
beled periventricularWMHs (PVWMHs) and all otherswere considered
deep WMHs (DWMHs).
To derive the subject-speciﬁc CBFmap each of the three runs of PASL
images was divided into labeled and controlled datasets. Each dataset
was linearly aligned to the initial ASL datasets (M0) and was inspected
for the excessive head movement (≥2 mm or 2°). The area outside of
the brain was excluded. The three runs were concatenated by linearly
aligning the ﬁrst and third runs to the second run. The M0 from the
three runs were averaged. Quantitative CBF was then calculated on a
voxel basis according toWang et al. (Wang et al., 2003). Voxel-wise par-
tial volume correction was performed (Du et al., 2006).
To determine the WMH CBF penumbra, a NAWM layer mask
for each individual dataset was created by linearly aligning the deﬁned
WMHs to the T1-weighted image. Each layer was dilated away from the
WMHs by 1 voxel (1 mm), for a total of 15 NAWM layers for PVWMH
and DWMH separately, see Fig. 1A–B. The innermost layer, closest to
WMH was layer 1 (NAWM-L1) and the outermost layer was layer 15
(NAWM-L15), see Fig. 1C. To prevent overlapping voxels between
layers, before creating the next layer, the WMH and the previous
NAWM layers were merged together to create a new ‘seed’. To avoid
the partial volume effects of the GM and CSF CBF, the GM and ventricu-
lar masks were dilated by 2 voxels, and subtracted from the NAWM
layers. The NAWM layer mask was individually applied to the CBF map,
which was previously linearly aligned to their T1-weighted image and
was resampled to 1 × 1 × 1 mm. Lastly, for each individual subject the
mean CBF for WMHs and each NAWM layer was computed for PVWMH
and DWMH separately, and compared with mean total brain NAWM
CBF. Each mean value was adjusted for age.
For the longitudinal study, we focused only on the PVWMH as it was
more prominent and consistent across subjects compared to DWMH
(Table 1). To measure the CBF of the new PVWMH voxels at follow-up
MRI, each individual3s follow-up FLAIR image was linearly aligned to
the same subject3s baseline FLAIR image. The voxels with newPVWMHs
Fig. 1.NAWM layermasks. (A) NAWM layermask for deepWMH. (B) NAWM layermask for periventricularWMH. (C) Enlarged periventricular NAWM layermask at the right ventricular
cap (black rectangular area on B).
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NAWM in follow-up, known as persistent NAWM voxels, were deﬁned.
The volume of newWMHs at follow-up was computed. Next, the base-
line NAWM layermaskwas applied to the aligned FLAIR images. Finally,
mean baseline CBF and follow-up CBF of new WMH and persistent
NAWM voxels of each layer were calculated.
2.4. Statistical analysis
The analyses were performed using SPSS software (v.20, IBM), SAS
(v.9.3, SAS Institute Inc.) and R (v.2.11, R Foundation). To compareFig. 2.Mean and standard error of baseline periventricular and deepWMH and its outer NAWM
WMH. Y-axis represents age-adjusted CBF. X-axis represents WMH and its NAWM layers (L1–
brain NAWM CBF, respectively. Asterisks represent signiﬁcant differences at p b 0.05.mean CBF between the WMH and NAWM layers (L1–L15) with mean
total brain NAWM CBF, a mixed effects model was used. In the model,
we created 15 dummy variables indicating each NAWM CBF layer
with total brain NAWM CBF as a reference. The analysis was performed
for PVWMH and DWMHs separately. To identify NAWM with substan-
tial growth of new WMH voxels for the longitudinal data, we ran a
mixed effects model with each layer being treated as a repeated obser-
vation (independent variables) and log transformed newWMH volume
as outcomes (to address the skewed distribution). We then ﬁtted the
curve with quadratic and cubic functions of layers, which provided the
best goodness of ﬁt. To compare mean baseline CBF between newlayers (L1–L15) in relation to total brain NAWMCBF. (A) PeriventricularWMH. (B) Deep
L15). The solid horizontal and dotted lines represent the mean and standard error of total
227N. Promjunyakul et al. / NeuroImage: Clinical 8 (2015) 224–229WMH voxels and persistent NAWM voxels, paired t-tests were used.
Signiﬁcant difference was set at p b 0.05.
3. Results
3.1. Lower CBF of WMH and NAWM layers compared to total brain NAWM
CBF
Fig. 2 shows a comparison of the WMH CBF and its NAWM layers
(L1–L15) with mean total brain NAWM CBF (Fig. 2A shows PVWMH;
Fig. 2B shows DWMH). For PVWMH, the mean age-adjusted CBF of
WMH and NAWM L1–L12 was signiﬁcantly lower than that of the CBF
of the mean total brain NAWM. For DWMH, the mean age-adjusted
CBF of WMH and NAWM L1–L11 was signiﬁcantly lower than that of
the mean total brain NAWM CBF. The mean (standard error, SE) age-
adjusted CBF of total brain NAWM was 0.32 (0.01) ml/100 g/min/
years old. Inline Supplementary Table S1 demonstrates the mean (SE)
age-adjusted CBF of the PVWMH, DWMH, their NAWM layers and
their p-values in relation to total brain NAWM CBF. A comparison be-
tween PVWMH and DWMH demonstrated that the CBF of PVWMH
and NAWM L1–L4 was signiﬁcantly lower than that of DWMH (see
Inline Supplementary Table S1).
Inline Supplementary Tables S1 can be found online at http://dx.doi.
org/10.1016/j.neuroimage.2012.08.028.
3.2. Reduced baseline CBF of new WMH voxels compared to persistent
NAWM voxels
For the longitudinal data, Fig. 3A shows the new WMH volume of
each NAWM layer at the follow-up MRI. The model with quadratic
and cubic terms demonstrated that at layer 6, the estimated value
reached below 0 in log transformed WMH values, indicating that there
is no substantial growth beyond layer 5. The group mean (SE) volumes
of newWMHwere NAWM-L1=478.4 (69.0)mm3, NAWM-L2=154.7
(24.2) mm3, NAWM-L3 = 52.0 (10.5) mm3, NAWM-L4 = 30.3 (7.0)
mm3, and NAWM-L5= 22.3 (6.2) mm3. For further longitudinal analy-
sis, we therefore focused on the innermost 5 layers.
Fig. 3B illustrates the average baseline CBF in NAWM-L1 to -L5 of
new WMH voxels in relation to voxels that persisted as NAWM at
follow-up. Themean baseline CBF of newWMHvoxelswas signiﬁcantly
lower than that of persistent NAWM voxels (14.08 (0.2) versus 17.66
(0.2) ml/100 g tissue/min, p = 0.006). The same ﬁgure also demon-
strates that the mean baseline CBF of new WMH voxels was lower
than that of the persistent NAWM voxels in each NAWM layer. There
was no signiﬁcant difference between the baseline and follow-up CBF
in eitherWMHs or its NAWM layers after amean follow-up of 18months
(see Inline Supplementary Fig. S1).
Inline Supplementary Fig. S1 can be found online at http://dx.doi.
org/10.1016/j.nicl.2015.04.012.
4. Discussion
The present study aimed to better understand blood ﬂow behavior
surrounding WMHs in cognitively intact elderly. There are two major
ﬁndings. First, the CBF of WMH and its NAWM layers was signiﬁcantly
lower than the mean total brain NAWM CBF up to layer 12 and layer
11 for PVWMH and for DWMH, respectively. This indicates a WMH
CBF penumbra that extends approximately 12mm from the established
WMH. Second, the reduced baseline CBF of voxelswith newWMHcom-
pared to those with persistent NAWM suggests that cross-sectional CBF
data could be used to predict the growth of WMH over time, and the
baseline CBF of the WMH penumbra can predict the development of
newWMH voxels at follow-up.
Results from this study show thatWMHCBF penumbra exists approx-
imately 12 mm surrounding WMHs. These results are consistent with a
previous study showing a WMH DTI-FA and FLAIR intensity penumbra,that was approximately 3–8 mm around WMHs (Maillard et al., 2011;
Maillard et al., 2014). Two possible reasons may explain the more exten-
sive penumbra area in the current study compared to the previous study.
First, the resolution of the ASL images is lower than the DTI images.
Accordingly, the WMH penumbra is on an order of 1–2 voxels, which is
consistent with the previous DTI observations. Second, ASL CBF may be
more sensitive for detecting ‘at risk’ tissue compared to DTI-FA in that
lower CBF likely precedes structural changes, such as reducedWM integ-
rity observed by DTI. The CBF penumbra would therefore likely extend
beyond the DTI-FA penumbra with structural damage occurring initially
at the inner, lowest CBF layers, sparing the outer layers of DTI-FA change
initially.
Both PVWMH and DWMH demonstrated reduced CBF in the neigh-
boring NAWM voxels within a similar extensive area, thus conﬁrming
the existence of a CBF penumbra surrounding chronic ischemic white
matter lesions, regardless of the different vasculatures and anatomies of
WMH subtypes. CBF of inner PVWMH NAWM layers (L1–L4) was signif-
icantly lower than similar inner NAWM layers of DWMHs, indicating po-
tentially varying pathophysiologies of the two WMH subtypes. Previous
work has shown that PVWMHs border zones between ventriculofugal
vessels and the penetrating centripetal vessels, which may cause water-
shed infarctions due to chronic hemodynamic insufﬁciency (De Reuck,
1971; Moody et al., 1997; Thomas et al., 2003). On the other hand,
DWMHs were likely associated with arteriolosclerosis (Fazekas et al.,
1993; Haller et al., 2013; Thomas et al., 2002), which alters the blood sup-
ply ofWMand leads to either localized ischemic areas of necrosis and cav-
itation or diffuse rarefaction (Kim et al., 2008; Pantoni and Garcia, 1997).
These underlying mechanistic differences in perfusion change between
the two WMH subtypes may affect quantitative WMH CBF values, but
did not result in differences in extension of the penumbra area.
Another important observation was that WMH CBF increased from
the inner to outer NAWM layers, suggesting that new WMHs expand
from the outer edge of the existing WMH lesion, and that the develop-
ment of WM injury is largely a continuous process. This ﬁnding is
consistent withMaillard et al. who showed that NAWMvoxels3 proxim-
ity toWMHs had a higher injury score than the voxels located in an area
distant fromWMHs (Maillard et al., 2011) and approximately 80% of the
growing WMH extends from existing lesions (Maillard et al., 2012).
Results from this study not only support previous ﬁndings, but also sug-
gest a plausible mechanism by which such observations are made,
i.e., lower CBF in the area immediately surrounding WMH lesions.
In this study, we deﬁned the WMH penumbra by comparing the
mean CBF of each NAWM layer to that of total brain NAWM voxels.
One could argue that the mean total brain CBF might be computed
largely from the sameNAWMvoxels, inﬂuencing the observed ﬁndings.
However, the WMH burden presented in our subjects was relatively
small, and the NAWM voxels for all ﬁfteen layers were only approxi-
mately 11.6% of the entire brain NAWM voxels.
Our longitudinal data demonstrated that, within the WMH CBF
penumbra area, baseline CBF could deﬁne NAWM voxels at greater
risk for becoming new WMHs from NAWM voxels that will likely re-
main NAWM in follow-up. To our knowledge, no previous study has
characterized the WMH CBF penumbra and validated it with a longitu-
dinal observation. We therefore cannot compare our ﬁndings to any
other studies. It is important to note that there was no signiﬁcant differ-
ence between the baseline and follow-up WMH CBF. This suggests that
CBF of degenerateWM thatwas shown as hyperintensities on FLAIR im-
ages may have reached a “ﬂoor” level, with decreased likelihood of
changing over time. Second, ASL WM CBF is reproducible, consistent
with previous studies which demonstrated excellent reproducibility of
WM CBF for healthy aging (Zhang et al., 2012).
White matter hyperintensities in the aging population are related to
both CBF and cerebral metabolism (DeCarli et al., 1995b; Frackowiak
et al., 1981; Takahashi et al., 2000; Yamaji et al., 1997). The decreased
CBF surrounding WMHs associated with new WMHs observed in this
study suggests that small vessel ischemia is the cause of WMHs.
Fig. 3. Longitudinal data. (A) Volume of new WMH voxels at follow-up. Each marker
represents themean and standard error (SE) of newWMHvoxels at eachNAWMlayer de-
ﬁned at baseline. New WMH volume was larger at the inner layers with no substantial
growth beyond layer 5. (B) Mean baseline CBF of NAWM layers 1, 2, 3, 4, and 5 and
mean of all 5 layers of new WMH voxels versus persistent NAWM voxels. X-axis is
NAWM layers. Y-axis is cerebral blood ﬂow. Asterisk represents signiﬁcant difference of
baseline CBF between the two voxel groups, p b 0.05.
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bralmetabolic decrease, rather than a solely ischemic phenomenon. Ac-
cordingly, age-related neurodegenerationmayoccur as a primary event,
resulting in decreased metabolic demands, which would subsequently
decrease metabolic supplies brought to the brain by CBF per regula-
tory mechanisms. In this case, WMH would be associated with a
coupled decline of CBF and metabolic rate of oxygen (CMRO2)
(Frackowiak et al., 1981). It also remains conceivable that WMH is
primarily associated with cerebral hypoperfusion, which, if long-
standing, may progressively lead to secondary metabolic alterations,
and reduction of CMRO2. In this case, either an increase in oxygen
extraction fraction (OEF) with the coupled decline of CBF and CMRO2 or
a decrease in CBF with preserved CMRO2 would be expected (Yamaji
et al., 1997). In our current study, we did not measure cerebral metabo-
lism inWMH and its corresponding NAWM. However, it would be inter-
esting for future studies to investigate the relation of CBF and cerebral
metabolism in the area surrounding WMH lesions.
This study is the ﬁrst to deﬁne a CBF penumbra for age-related
WMHs, and supports previous literature demonstrating that WMHs
are likely ischemic in origin. The WMH CBF penumbra modeling used
in this study provides an absolute distance of the penumbra from
WMH lesions, and thus representing a potentiallymodiﬁable biomarker
that can gauge those at risk forWMHprogression. TheASLMRImethods
of CBF determination used in this study are preferable to investigate
cerebrovascular health in an aging population for a number of reasons.
It is noninvasive, and does not require the use of intravenous contrast
agents or radioactive tracers. Information can be acquired during the
same imaging session that structural data are obtained, including cere-
brovascular disease burden. Furthermore, newer ASL sequences, such as
continuous ASL (CASL) and pseudo-continuous ASL (PCASL), can ac-
quire perfusion data similar to that reported here in a shorter amount
of time, thus making ASL MRI perfusion imaging compatible with rou-
tine clinical scanning.
The ability to assess and monitor WM at risk for future ischemic in-
jury has several important clinical implications. The optimal degree of
blood pressure management of older individuals is currently unclear
as current guidelines might be too aggressive in some individuals with
impaired cerebral autoregulation, resulting in an overall decreased per-
fusion pressure (Muller et al., 2014). This ASL MRI technique could be
used to more directly assess the effects of blood pressure management
on WM perfusion and functional outcomes. Similar methods could be
used to monitor treatment effects and to validate other interventions
aimed at repressing the growth of WMH over time via mechanisms
aimed at enhancing cerebral perfusion, such as those involving exercise
(Hiura et al., 2014) or meditation (Newberg et al., 2010).
Limitations of this study include a relatively small sample size, par-
ticularly in the second visit. Secondly, studies to assess relationships of
WMH CBF penumbra and clinical manifestations of cognitive and
motor performance should be done. Thirdly, further studies to precisely
identify a baseline CBF value that could reliably differentiate voxels that
will contain newWMHs from thosewith persistent NAWMat follow-up
are needed. Fourthly, further studies investigatingWMH andWMHCBF
penumbra at the lesion-level should be included. Lastly, a longer follow-
up should be pursued.
5. Conclusions
In conclusion, the present study provides important implication
regarding the etiology of WMH expansion, a phenomenon commonly
observed in older individuals, and associatedwith signiﬁcantmorbidity.
Lower CBF in the surrounding area of WMHs indicates a penumbra, or
tissue at risk for developing into a WM lesion. The longitudinal data
show that the WMH penumbra is associated with WMH expansion
over time and that lower CBF precedes developing new WMH voxels.
The CBF penumbra can be used as amodiﬁable biomarker tomonitor ef-
fects of prevention and treatment trials targeting improved cerebralblood ﬂow in order to maintain cognitive and motor function in the
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